Cyclic nucleotide content and phosphodiesterase activity in the rds mouse (020/A) retina

Exp Eye Res. 1984 Mar;38(3):247-56. doi: 10.1016/0014-4835(84)90163-5.

Abstract

Cyclic nucleotide metabolism was examined in the retina and in the retinal pigment epithelium (RPE)-choroid complex of the rds mouse (020/A), a mutant in which discrete photoreceptor outer segment disc structures fail to develop. In retinas of both rds and control (Balb/c) mice, cyclic AMP levels peak at 10-15 days (20-25 pmol mg-1 protein). The level drops to about 10 pmol mg-1 at about one month in normal retinas but remains high in affected retinas. Cyclic GMP levels increase five-fold in Balb/c retinas as ROS develop whereas, in affected retinas, the levels remain constant and low (about 5 pmol mg-1). In RPE-choroid, cyclic nucleotide levels are similar in control and affected mice. Cyclic AMP phosphodiesterase (PDE) activity is somewhat higher in affected than in control retinas; conversely, cyclic GMP-PDE is lower. Both cyclic AMP-PDE and cyclic GMP-PDE activities are different in normal and affected RPE-choroid. Thus, although the rds (020/A) mouse belongs to the early-onset photoreceptor dysplasia group of hereditary retinal degenerations on a morphological basis, it does not exhibit high retinal cyclic GMP levels and thus appears to be distinct from other animals exhibiting early postnatal photoreceptor dysfunction.

MeSH terms

  • 3',5'-Cyclic-AMP Phosphodiesterases / metabolism*
  • 3',5'-Cyclic-GMP Phosphodiesterases / metabolism*
  • Age Factors
  • Animals
  • Cyclic AMP / metabolism*
  • Cyclic GMP / metabolism*
  • Mice
  • Mice, Mutant Strains
  • Mutation
  • Pigment Epithelium of Eye / pathology
  • Retina / growth & development
  • Retina / metabolism*
  • Retina / pathology
  • Retinal Degeneration / genetics
  • Retinal Degeneration / metabolism*

Substances

  • Cyclic AMP
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic GMP